164 related articles for article (PubMed ID: 24962950)
1. Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.
Maletzki C; Klier U; Marinkovic S; Klar E; Andrä J; Linnebacher M
Oncotarget; 2014 Jun; 5(12):4467-79. PubMed ID: 24962950
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic designer host defense peptide suppresses growth of human liposarcoma.
Steinstraesser L; Schubert C; Hauk J; Becerikli M; Stricker I; Koeller M; Hatt H; von Duering M; Shai Y; Steinau HU; Jacobsen F
Int J Cancer; 2011 Jun; 128(12):2994-3004. PubMed ID: 20734391
[TBL] [Abstract][Full Text] [Related]
3. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic activities of host defense peptides.
Al-Benna S; Shai Y; Jacobsen F; Steinstraesser L
Int J Mol Sci; 2011; 12(11):8027-51. PubMed ID: 22174648
[TBL] [Abstract][Full Text] [Related]
5. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
[TBL] [Abstract][Full Text] [Related]
6. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
Steinstraesser L; Hauk J; Al-Benna S; Langer S; Ring A; Kesting M; Sudhoff H; Becerikli M; Käfferlein H; Jacobsen F
Drug Chem Toxicol; 2012 Jan; 35(1):96-103. PubMed ID: 21851146
[TBL] [Abstract][Full Text] [Related]
7. Swine-Derived Probiotic
Wang J; Zhang W; Wang S; Liu H; Zhang D; Wang Y; Ji H
Front Immunol; 2019; 10():2691. PubMed ID: 31803195
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
Wilms D; Andrä J
J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
[TBL] [Abstract][Full Text] [Related]
9. Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
Hazini A; Pryshliak M; Brückner V; Klingel K; Sauter M; Pinkert S; Kurreck J; Fechner H
Hum Gene Ther; 2018 Nov; 29(11):1301-1314. PubMed ID: 29739251
[TBL] [Abstract][Full Text] [Related]
10. Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.
Maletzki C; Stier S; Gruenert U; Gock M; Ostwald C; Prall F; Linnebacher M
PLoS One; 2012; 7(12):e52485. PubMed ID: 23300683
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
12. An Oncolytic Adenovirus Expressing SNORD44 and GAS5 Exhibits Antitumor Effect in Colorectal Cancer Cells.
Yuan S; Wu Y; Wang Y; Chen J; Chu L
Hum Gene Ther; 2017 Aug; 28(8):690-700. PubMed ID: 28530127
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.
Inoda S; Morita R; Hirohashi Y; Torigoe T; Asanuma H; Nakazawa E; Nakatsugawa M; Tamura Y; Kamiguchi K; Tsuruma T; Terui T; Ishitani K; Hashino S; Wang Q; Greene MI; Hasegawa T; Hirata K; Asaka M; Sato N
Exp Mol Pathol; 2011 Feb; 90(1):55-60. PubMed ID: 20950610
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus.
Gao H; Zhang X; Ding Y; Qiu R; Hong Y; Chen W
Technol Cancer Res Treat; 2019; 18():1533033819853290. PubMed ID: 31138083
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies.
O'Neill MJ; Chan K; Jaynes JM; Knotts Z; Xu X; Abisoye-Ogunniyan A; Guerin T; Schlomer J; Li D; Cary JW; Rajasekaran K; Yates C; Kozlov S; Andresson T; Rudloff U
J Pharm Biomed Anal; 2020 Mar; 181():113093. PubMed ID: 31931447
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
18. A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
Wang B; Ogata H; Takishima Y; Miyamoto S; Inoue H; Kuroda M; Yamada K; Hijikata Y; Murahashi M; Shimizu H; Okazaki T; Nakanishi Y; Tani K
Anticancer Res; 2018 Nov; 38(11):6121-6126. PubMed ID: 30396927
[TBL] [Abstract][Full Text] [Related]
19. Combining bacterial-immunotherapy with therapeutic antibodies: a novel therapeutic concept.
Klier U; Maletzki C; Kreikemeyer B; Klar E; Linnebacher M
Vaccine; 2012 Apr; 30(17):2786-94. PubMed ID: 22342917
[TBL] [Abstract][Full Text] [Related]
20. Does an Apple a Day Also Keep the Microbes Away? The Interplay Between Diet, Microbiota, and Host Defense Peptides at the Intestinal Mucosal Barrier.
Puértolas-Balint F; Schroeder BO
Front Immunol; 2020; 11():1164. PubMed ID: 32655555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]